Target intelligence / Profile preview

Enhancement of endogenous repair processes

Molecular classification
Other
01

Overview

"Enhancement of endogenous repair processes" refers to therapeutic or physiological approaches aimed at stimulating the body's own natural repair and regeneration mechanisms, typically by mobilizing resident stem/progenitor cells, modulating the local immune microenvironment, or by manipulating molecular signaling pathways involved in tissue regeneration and homeostasis[1][2][3][5][6]. Unlike targeting a single protein or receptor, this strategy encompasses a diverse set of biological activities (e.g. Wnt signaling, BMP activation, VEGF-mediated angiogenesis, stem cell activation, and immune modulation) that promote restoration of tissue structure and function following injury or disease[1][3]. This is a promising frontier in regenerative medicine but does not correspond to a single defined molecular or pharmacological target.

Other names
Endogenous repairEndogenous regenerationEnhancement of endogenous regenerationStimulation of endogenous repair
02

Mechanism of action

Promotion of stem/progenitor cell recruitment and differentiation[1][2][3] Modulation of immune and inflammatory responses to favor regeneration over fibrosis[3][5] Activation of signaling pathways relevant to tissue repair (e.g. Wnt/β-catenin, BMP, VEGF, HIF-1α)[1][3] Suppression of pro-inflammatory or fibrotic signaling[1][5] Enhancement of angiogenesis and extracellular matrix remodeling[1][3]

03

Biological functions

Tissue regenerationCell proliferationWound healingStem/progenitor cell activationImmune modulationAngiogenesis
04

Disease associations

Tissue injury (general)Degenerative diseaseNeurodegenerationMusculoskeletal disordersCartilage repairAging-related tissue declineOther
05

Safety considerations

Risk of aberrant tissue growth or fibrosis if repair signals are dysregulated[5]Potential for tumorigenesis if uncontrolled proliferation is inducedInflammatory or immune-related adverse reactions (context- and agent-specific)[5]
06

Interacting drugs

growth factors

5 more in the full profile.

07

Biomarkers

Levels of tissue-specific growth factors (e.g. BMPs, VEGF)Markers of stem/progenitor cell activation/differentiationInflammation and pro-regenerative cytokinesTissue remodeling and healing indices (context-dependent)

Beyond the preview

Go deeper on Enhancement of endogenous repair processes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enhancement of endogenous repair processes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call